Insulin du jour.
One of the myriad side effects of a healthcare system run by back-room deals between Big Pharma and big insurance companies. | Ofri, New York Times 2019
Search This Blog
With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day's most pertinent cancer news.
- Get link
- Other Apps
Labels
Comments
Post a Comment